Belgium· BE-AMP-SAM122814-00
Litican 12 mg/ml
A alizapride product containing alizapride hydrochloride, registered in Belgium by Sanofi Belgium. The same ATC class is registered in 3 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Alizapride is registered in 3 of 19 countries.
Countries holding a registration under ATC A03FA05 (alizapride), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 3 of them publish a price we can compare per daily dose
Alizapride · ATC A03FA05
3 / 19 countries
- Belgiumprice
- Italyprice
- Norwayprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Alizapride Hydrochloride
- Manufacturer
- Sanofi Belgium
- Country
- Belgium (BE)
- ATC code
- A03FA05
- ATC class
- Alizapride
- Defined daily dose
- 0.15 g, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Alizapride in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FrancePLITICAN, solution injectableSANOFI WINTHROP INDUSTRIE
- ItalyLIMICAN*4 fiale IM EV 50 mg 2 mlACARPIA FARMACEUTICI Srl
- NorwayLiticansanofi-aventis (2)
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- France · Plitican
- Italy · Limican
- Luxembourg · Litican
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6aff31b7-2697-47a5-a284-5b5c88e475ef GET /v1/drugs/6aff31b7-2697-47a5-a284-5b5c88e475ef?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oral drops, solution",
"source": "afmps",
"status": "REVOKED",
"name_en": "Litican 12 mg/ml",
"name_fr": "Litican 12 mg/ml",
"name_nl": "Litican 12 mg/ml",
"amp_code": "SAM122814-00",
"strengths": [
"12.0000"
],
"pack_count": 1,
"substances": [
"Alizapride Hydrochloride",
"Alizapride"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Alizapride",
"authorisation_numbers": [
"BE122814"
]
}See everything about alizapride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.